Streetwise Live! Presents Algernon Pharmaceuticals on 01/27/2022. Learn More

The Latest Psychedelics Articles from Streetwise Reports

Trial of Psilocybin Therapeutic in Treatment Resistant Depression Yields Positive Topline Results

Research Report
"We believe this data begins to form the basis of an approvable program for Compass Pathways' COMP360" in this indication, noted a BTIG report.

US DEA OKs Use of Psychedelics by This Mental Health Network

Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment.

Psychedelic Drug Trials Accelerate as Decriminalization Spreads, Investment Expands

Contributed Research
McAlinden Research Partners estimates it may be only a matter of time before psychedelics become part of a biotech boom.

Showing Results: 1 to 3 of 3

Get Our Streetwise Reports Resources Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

More Experts

"I used the mill commissioning delay to add some positions in MAG."
– Chen Lin, What Is Chen Buying? What Is Chen Selling?